Mucosal Leishmaniasis: An Underestimated Presentation of a Neglected Disease

Author:

Strazzulla Alessio1ORCID,Cocuzza Salvatore2,Pinzone Marilia Rita1ORCID,Postorino Maria Concetta3ORCID,Cosentino Stefano1,Serra Agostino2,Cacopardo Bruno1ORCID,Nunnari Giuseppe1ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Clinical and Molecular Biomedicine, Garibaldi Nesima Hospital, University of Catania, 95125 Catania, Italy

2. Division of Otorhinolaryngology, Department of Medical-Surgical Specialties, Policlinico-Vittorio Emanuele Hospital, University of Catania, 95125 Catania, Italy

3. Division of Pathology and Experimental Microbiology, Elie Metchnikoff Department, University of Messina, 98125 Messina, Italy

Abstract

We present a review of current knowledge about mucosal leishmaniasis (ML). Although involvement of mucous membranes is classically admitted in New World leishmaniasis, particularly occurring in infection byLeishmania (L.) braziliensisspecies complex, ML is also a possible presentation of Old World leishmaniasis, in eitherL. donovaniorL. majorspecies complex infections. Thus, ML has to be considered not only as a Latin American disease but as an Old and New World disease. We describe ML epidemiology, pathogenesis, clinics, diagnosis, and therapy. Considering both its highly disfiguring lesions and its possible lethal outcome, ML should not be underestimated by physicians. Moreover, leishmaniasis is expected to increase its burden in many countries as sandfly vector distribution is widespreading towards non-endemic areas. Finally, the lack of clear understanding of ML pathogenesis and the absence of effective human vaccines strongly claim for more research.

Publisher

Hindawi Limited

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Investigational new drugs for the treatment of leishmaniasis;Expert Opinion on Investigational Drugs;2024-09-10

2. Clinical spectrum of nasal involvement in cutaneous leishmaniasis;International Journal of Dermatology;2024-06-06

3. Behandlung der mukokutanen Leishmaniose – eine systematische Übersicht;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-06

4. Treatment of mucocutaneous leishmaniasis – A systematic review;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-05-20

5. Laryngeal Leishmaniasis: A Neglected, Emerging Disease in Northern Italy;Journal of Voice;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3